Literature DB >> 7932424

Sleep cycles and alpha-delta sleep in fibromyalgia syndrome.

J Branco1, A Atalaia, T Paiva.   

Abstract

OBJECTIVE: Fibromyalgia syndrome (FMS) is a musculoskeletal disorder characterized by generalized pain, localized tender points, chronic fatigue and nonrestorative sleep. Since sleep disturbances frequently occur in FMS and alpha intrusion in nonrapid eye movement (NREM) sleep probably associates with the nonrefreshing sleep, we prospectively studied the delta and alpha activity and alpha-delta ratio across sleep cycles, performing polysomnography in 10 patients with FMS and in 14 healthy control subjects.
METHODS: Night long polysomnography recordings were performed in all subjects. Sleep scoring was done visually according to Rechtschaffen and Kales criteria. By means of spectral analysis the conventional electroencephalogram (EEG) frequency bands were automatically computed for the all night recordings. For alpha and delta power the integrated and normalized values were calculated for each sleep cycle, the evolution of these activities across successive sleep cycles was studied.
RESULTS: Alpha-delta patterns occurred in almost all the patients who had also superficial and fragmented sleep with increased awakenings and reduced REM and slow wave sleep. Delta decay across sleep cycles was different in FMS and alpha activity was greater and declined, whereas the controls were persistently low throughout their sleep. Alpha-delta ratio increased progressively in successive sleep cycles; this was again different from controls.
CONCLUSION: Patients with FMS presented a high frequency of subjective sleep disturbances, an increased incidence of alpha EEG NREM sleep and clear abnormalities in sleep cycle organization.

Entities:  

Mesh:

Year:  1994        PMID: 7932424

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  30 in total

Review 1.  The role of sleep in pain and fibromyalgia.

Authors:  Ernest H S Choy
Journal:  Nat Rev Rheumatol       Date:  2015-04-28       Impact factor: 20.543

2.  Predictors of clinical pain in fibromyalgia: examining the role of sleep.

Authors:  Ryan J Anderson; Christina S McCrae; Roland Staud; Richard B Berry; Michael E Robinson
Journal:  J Pain       Date:  2012-03-03       Impact factor: 5.820

3.  Prevalence and correlates of alpha-delta sleep in major depressive disorders.

Authors:  Nattapong Jaimchariyatam; Carlos L Rodriguez; Kumar Budur
Journal:  Innov Clin Neurosci       Date:  2011-07

Review 4.  Polysomnographic characteristics in nonmalignant chronic pain populations: A review of controlled studies.

Authors:  Martin F Bjurstrom; Michael R Irwin
Journal:  Sleep Med Rev       Date:  2015-04-08       Impact factor: 11.609

Review 5.  Fibromyalgia: from pathophysiology to therapy.

Authors:  Tobias Schmidt-Wilcke; Daniel J Clauw
Journal:  Nat Rev Rheumatol       Date:  2011-07-19       Impact factor: 20.543

6.  Sleep in rheumatic diseases and other painful conditions.

Authors:  Luis F Buenaver; Michael T Smith
Journal:  Curr Treat Options Neurol       Date:  2007-09       Impact factor: 3.598

7.  Power spectral analysis of sleep EEG in twins discordant for chronic fatigue syndrome.

Authors:  Roseanne Armitage; Carol Landis; Robert Hoffmann; Martha Lentz; Nathaniel Watson; Jack Goldberg; Dedra Buchwald
Journal:  J Psychosom Res       Date:  2008-11-25       Impact factor: 3.006

8.  Impaired sleep quality in fibromyalgia: Detection and quantification with ECG-based cardiopulmonary coupling spectrograms.

Authors:  Robert Joseph Thomas; Joseph E Mietus; Chung-Kang Peng; Ary L Goldberger; Leslie J Crofford; Ronald D Chervin
Journal:  Sleep Med       Date:  2009-12-16       Impact factor: 3.492

Review 9.  The comorbidity of insomnia, chronic pain, and depression: dopamine as a putative mechanism.

Authors:  Patrick H Finan; Michael T Smith
Journal:  Sleep Med Rev       Date:  2012-06-29       Impact factor: 11.609

Review 10.  Fibromyalgia: an overview.

Authors:  Diane Thompson; Louise Lettich; Junji Takeshita
Journal:  Curr Psychiatry Rep       Date:  2003-07       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.